Qi He

Wilshire Advisors LLC (Wilshire) is a privately-held investment technology and advisory firm headquartered in Santa Monica, California. The firm was founded by Dennis Tito in 1972 as Wilshire Associates, Inc. Wilshire provides innovative investment solutions, consulting services and multi-asset analytics to institutional and intermediary clients worldwide.

HuaAn Fund Management Co., Ltd. (HuaAn Funds) is a fund management firm headquartered in Shanghai, China. The firm was founded in 1998 and is owned by Guotai Junan Securities Co., Ltd. (SHA: 601211). HuaAn Funds provides a range of investment products and advisory services for domestic and international individual and institutional clients.

Harfor Fund Management Co., Ltd. (HFM), previously known as Huafu Fund Management, is an independent investment management firm which was founded in 2004. Shareholders include Hua An Securities Co., Xingtai Holding and Anhui Guaranty Group. Headquartered in Shanghai, HFM provides financial services to fund holders. They also manage mutual funds and accept direct mandates from individuals and institutions for asset management services.

Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong.

SWS Research Co., Ltd. is the investment research subsidiary of Shenwan Hongyuan Securities Co., Ltd., which is owned by Shenwan Hongyuan Group Co., Ltd. (SHE: 000166) in China. Headquartered in Shanghai, the firm was founded in 1992 to offer a wide range of products and services to global investors who want to invest in Chinese equity market. SWS Research provides clients with securities research service that covers over 500 key stocks in Asian market, as well as economics, strategy, bond, fund and derivatives research. Their clients include almost all major domestic institutional investors such as mutual funds, insurance companies, banks and trusts. They also serve QFII and other overseas institutional investors.

The Chinese Institute of Certified Public Accountants operates as an accounting organization. The private company is based in Beijing, China.

Shanghai Sansheng Hongye Investment (Group) Co., Ltd. engages in the real estate development, science & technology, big data, marine investment, urban construction and modern life service industries. The company was founded in 1993 and is headquartered in Shanghai, China.

Deloitte Touche Tohmatsu Ltd. provides auditing, financial advisory, tax, and consulting services. Its serves technology, consumer business, energy and resources, financial services, life sciences and health care, manufacturing, public sector, real estate, technology, media, and telecommunications industries. The company was founded in 1880 and is headquartered in New York, NY.

Shanghai Kaijie Ecommerce Co., Ltd. provides one-stop electronic-commerce solutions and Internet marketing services, which mainly target at industries of hotels and fast-moving consumer goods. It engages in business-to-business and business-to-consumer sale that based on third-party electronic-business platforms, and data-based marketing services. The company was founded by Hao Xu and Song Yu Han on July 19, 2010 and is headquartered in Shanghai, China.

Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA.

Hesai Technology Co., Ltd. designs and manufactures laser sensors. It offers 3-dimensional scanners for self-driving cars and robots; and gas leak remote sensors for natural gas industry. The company was founded by Kai Sun, Yifan Li and Shaoqing Xiang in 2013 and is headquartered in Shanghai, China.

Jiangsu Beiren Smart Manufacturing Technology Co., Ltd. engages in robot system integration, intelligence, and welding automation equipment. Its business includes robot development, design, automation equipment, industrial maintenance, and technology system development. The company was founded on December 26, 2011 and is headquartered in Suzhou, China.

The Association of International Certified Professional Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The joint venture company is based in Durham, NC and has subsidiaries in the United Kingdom and United States. The organization is a leading authority in the field of accounting and finance, advocating for the profession, public interest, and business sustainability.

Shenzhen Jingtai Technology Co., Ltd. is a company that researches and develops biotechnology products. The company is based in Shenzhen, China. The Chinese company was founded in 2015 by Shu Hao Wen, Jian Ma, Li Peng Lai. Jian Ma has been the CEO since 2015.

NuProbe USA, Inc. engages in the development of ultra-sensitive and multiplexed platform with reagents for non-invasive nucleic acid profiling and diagnostics. The firm offers VarTrace EGFR Assay, VarTrace BFAR Assay, and VarTrace AML multi-gene panel. The company was founded by Peng Yin, David Yu Zhang, and Victor Chenyang Shi in 2016 and is headquartered in Cambridge, MA.

Refuge Biotechnologies, Inc. develops therapeutic cells. It is leveraging gene engineering technologies known as CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) to develop therapeutic cells that are programmed to make decisions inside the patient’s body. The firms programs include RB-1916, RB-H21 and RB-M1. The company was founded by Stanley Qi, David R. Parkinson and Bing C. Wang and is headquartered in Menlo Park, CA.

ComNav Technology Ltd. develops and manufactures multi-constellation, multi-frequency GNSS measurement engine boards and receivers for demanded applications. Its technology already been used in applications such as surveying, construction, machine control, agriculture, intelligent transportation, precise timing, deformation monitoring, unmanned system. The company was founded by Wang Yongquan on February 28, 2012 and is headquartered in Shanghai, China.

Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China.

Marketingforce Management Ltd. is a holding company, which engages in the provision of sale of software as a service solution provider and precision marketing services. The company was founded on February 23, 2021 and is headquartered in Shanghai, China.

Wuhan Neurophth Biotechnology Co., Ltd. is a leading in-vivo gene therapy company for ophthalmic diseases based in Wuhan, China. The Chinese company's core product, nr082 (nfs-01), is designed to treat ND4-mediated Leber's hereditary optic neuropathy (ND4-LHON) and has been granted orphan drug designation (ODD) by the FDA and EMA. It is the first Chinese gene therapy new drug that has been granted IND approval for clinical trials by the Chinese National Medical Products Administration (NMPA) and the FDA. The company's pipeline also includes ND1-mediated LHON, autosomal dominant optic atrophy, optic nerve protection, vascular retinopathy, and other preclinical candidates. The company was founded in 2016 by Bin Li, Su Xiao, Dabo Cai, and Bin Li has been the CEO since then.

Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin.